The prediction of breast cancer biopsy outcomes using two CAD approaches that both emphasize an intelligible decision process.
By M. Elter, R. Schulz-Wendtland, Thomas Wittenberg. 2007
277 citations recorded by the source corpus.
Subfields: Artificial Intelligence, Molecular Biology, Oncology, Medical & Health AI
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Artificial Intelligence
- Cynthia Rudin
- Berk Ustun
- Bernt Schiele
- Matthias Hein
- Maksim Lapin
- Yiyun Zhang
- Alina Jade Barnett
- Chih-Ling Tsai
In Molecular Biology
- Benjamin Letham
- Cynthia Rudin
- Bernt Schiele
- Matthias Hein
- Runze Li
- Yiyun Zhang
- Alina Jade Barnett
- Chih-Ling Tsai
In Oncology
In Medical & Health AI
- Cynthia Rudin
- Berk Ustun
- Jean-Daniel Zucker
- Yann Chevaleyre
- Nataliya Sokolovska
- Benjamin Letham
- Karine Clément
- Matthias Hein
Citations in the corpus
- A case-based interpretable deep learning model for classification of mass lesions in digital mammography (2021, background): “Some studies have reported better performance in predicting malignancy from BI-RADS features [19, 6, 7].”
- Learning Optimized Risk Scores (2016, background): “3% person has breast cancer Elter et al. (2007) mushroom 8,124 113 48.”
- Falling Rule Lists (2014, neutral): “|{ y n } ; { x n } , H ).”
- Building Interpretable Classifiers with Rules using Bayesian Analysis (2012, methodology): “We compared algorithm performance on a collection of datasets from the UCI Machine Learning Repository [13]: Tic-Tac-Toe Endgame, Mammographic Mass [11], Titanic, Breast Cancer Wisconsin (Original) [28], and Adult.”
- Learning using privileged information: SV M+ and weighted SVM (2013, background): “Mammographic Mass (Elter et al., 2007): Again, the weight learning performs on par or better than the SVM on all splits for almost all subsets.”
- Regularization Parameter Selections via Generalized Information Criterion (2010, methodology): “To examine the capability of two novel CAD approaches, Elter, Schulz-Wendtland, and Wittenberg (2007) recently analyzed a dataset containing 516 benign and 445 malignant instances.”
- The fused lasso penalty for learning interpretable medical scoring systems (2017, background): “• Mammographic Mass Data Set is dedicated to discrimination of benign and malignant mammographic masses [16].”